Applicant, as named in the Orange Book
Avid Radiopharms Inc
Next listed expiry: Amyvid on 30 Apr 2027. 2 products with live protection, 0 without.
Products with listed protection
| Drug | Ingredient | NDA | Earliest generic entry | Basis |
|---|
| Amyvid · 2 strengths florbetapir f-18 | florbetapir f-18 | 202008 | 30 Apr 2027 | patent |
| Tauvid · 2 strengths flortaucipir f-18 | flortaucipir f-18 | 212123 | 26 May 2032 | patent |
Recent events
- 24 Oct 2026Amyvid · Enters 12-month window basis: patent30 Apr 2027
- 24 Oct 2026Amyvid · Enters 12-month window basis: patent30 Apr 2027
- 24 Oct 2026Amyvid · Enters 12-month window basis: patent30 Apr 2027
- 24 Oct 2026Amyvid · Enters 12-month window basis: patent30 Apr 2027